Browse by author
Lookup NU author(s): Dr Olivier Barbeau, Dr Celine CanoORCiD, Professor Roger Griffin, Dr Ian HardcastleORCiD, Professor William Clegg, Dr Ross Harrington, Emeritus Professor Bernard Golding
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
8- Substituted 2- morpholin- 4- yl- quinolin- 4- ones and 9- substituted 2- morpholin- 4- ylpyrido[ 1,2- a] pyrimidin- 4- ones with selected aryl and heteroaryl groups as the substituent have been synthesised as potential inhibitors of DNA- dependent protein kinase. A multiple- parallel approach, employing Suzuki cross- coupling methodology, was utilised in the preparation of 8- substituted 2- morpholin- 4- yl- quinolin- 4- ones. For this purpose 8- bromo- 2- morpholin- 4- yl- quinolin- 4- one was required as an intermediate. This compound was obtained by adapting a literature route in which thermal cyclocondensation of ( 2- bromoanilino)- morpholin- 4- yl- 5- methylene- 2,2- dimethyl[ 1,3] dioxane4,6- dione afforded 8- bromo- 2- morpholin- 4- yl- quinolin- 4- one. A multiple- parallel approach, employing Suzuki cross- coupling methodology, was also utilised to prepare 9- substituted 2- morpholin- 4- ylpyrido[ 1,2- a] pyrimidin- 4- ones using 9- hydroxy- 2- morpholin- 4- yl- pyrido[ 1,2- a] pyrimidin- 4- one O- trifluoromethanesulfonate as an intermediate. 8- Substituted 2- morpholin- 4- yl- quinolin- 4- ones and 9- substituted 2- morpholin- 4- yl- pyrido[ 1,2- a] pyrimidin- 4- ones were both inhibitors of DNA- dependent protein kinase. When the substituent was dibenzothiophen- 4- yl, dibenzofuran- 4- yl or biphen- 3- yl, IC50 values in the low nanomolar range were observed. Interestingly, the pyridopyrimidinones and quinolinones were essentially equipotent with the corresponding 8- substituted 2- morpholin- 4yl- chromen- 4- ones previously reported ( I. R. Hardcastle, X. Cockcroft, N. J. Curtin, M. Desage El- Murr, J. J. J. Leahy, M. Stockley, B. T. Golding, L. Rigoreau, C. Richardson, G. C. M. Smith and R. J. Grif. n, J. Med. Chem., 2005, 48, 7829 - 7846).
Author(s): Barbeau OR, Cano-Soumillac C, Griffin RJ, Hardcastle IR, Smith GCM, Richardson C, Clegg W, Harrington RW, Golding BT
Publication type: Article
Publication status: Published
Journal: Organic & Biomolecular Chemistry
Year: 2007
Volume: 5
Issue: 16
Pages: 2670-2677
ISSN (print): 1477-0520
ISSN (electronic): 1477-0539
URL: http://dx.doi.org/10.1039/b705095j
DOI: 10.1039/b705095j
PubMed id: 18019542
Altmetrics provided by Altmetric
